ALBUTEROL SULFATE AND BUDESONIDE

ALBUTEROL SULFATE AND BUDESONIDE was reported 1599 times

ALBUTEROL SULFATE AND BUDESONIDE is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 EXERCISE ADEQUATE 1 0.1000
1 INFLUENZA A VIRUS TEST 1 0.0556
2 BREAST ANGIOSARCOMA 1 0.0400
3 CONGENITAL NEUROPATHY 1 0.0400
4 BLADDER WALL CALCIFICATION 1 0.0370
5 KALEIDOSCOPE VISION 1 0.0312
6 HYPOPHENYLALANINAEMIA 1 0.0312
7 TENODESIS 1 0.0303
8 PERIPHERAL NERVE NEUROSTIMULATION 1 0.0303
9 EXPOSURE TO HOUSEHOLD CHEMICALS 1 0.0294
10 DIHYDROTESTOSTERONE DECREASED 1 0.0278
11 RESIDUAL SYMPTOM 1 0.0263
12 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS PERFORMED IN ERROR 16 0.0260
13 MAMMARY DUCT ECTASIA 1 0.0222
14 FUNCTIONAL RESIDUAL CAPACITY DECREASED 1 0.0196
15 PULMONARY FUNCTION TEST 1 0.0179
16 INTENTIONAL DEVICE USE ISSUE 15 0.0175
17 HAEMOPHILUS SEPSIS 1 0.0175
18 LARYNGITIS FUNGAL 2 0.0155
19 DEVICE DELIVERY SYSTEM ISSUE 422 0.0154
20 CARDIAC RESYNCHRONISATION THERAPY 1 0.0141
21 BRONCHOSPASM PARADOXICAL 4 0.0133
22 MUSCLE TENSION DYSPHONIA 1 0.0125
23 COUGH VARIANT ASTHMA 1 0.0119
24 DRUG DELIVERY SYSTEM ISSUE 23 0.0117
25 ASTHMA EXERCISE INDUCED 4 0.0115
26 EXCESSIVE EXERCISE 1 0.0105
27 OLIGOSPERMIA 1 0.0097
28 TOOTH DEMINERALISATION 1 0.0095
29 FUNGAL RHINITIS 1 0.0093
30 ALLERGIC BRONCHITIS 1 0.0090
31 PRODUCT CLEANING INADEQUATE 24 0.0090
32 IRON METABOLISM DISORDER 1 0.0084
33 CHARLES BONNET SYNDROME 1 0.0083
34 TRACHEOSTOMY INFECTION 1 0.0082
35 BRONCHOMALACIA 1 0.0076
36 CERVICOGENIC HEADACHE 1 0.0074
37 DEVICE USE ISSUE 128 0.0073
38 PRODUCT INFORMATION CONTENT COMPLAINT 2 0.0072
39 DEVICE MAINTENANCE ISSUE 4 0.0068
40 PRODUCT WITH QUALITY ISSUE ADMINISTERED 3 0.0067
41 PRODUCT IDENTIFICATION NUMBER ISSUE 1 0.0067
42 CATHETER SITE MASS 1 0.0066
43 JOINT INJECTION 1 0.0065
44 LUMBOSACRAL RADICULOPATHY 1 0.0062
45 CONTRAINDICATED DEVICE USED 2 0.0062
46 DEVICE USE CONFUSION 3 0.0057
47 INCORRECT DOSE ADMINISTERED BY PRODUCT 9 0.0056
48 ORAL BACTERIAL INFECTION 1 0.0055
49 CUTANEOUS CALCIFICATION 1 0.0055
50 ADMINISTRATION SITE DISCOMFORT 1 0.0053
51 SIGHT DISABILITY 1 0.0053
52 PRODUCT DELIVERY MECHANISM ISSUE 28 0.0052
53 INCORRECT DOSE ADMINISTERED BY DEVICE 130 0.0050
54 AUTOINFLAMMATORY DISEASE 1 0.0047
55 ACTIVITIES OF DAILY LIVING DECREASED 3 0.0047
56 TEMPOROMANDIBULAR PAIN AND DYSFUNCTION SYNDROME 2 0.0047
57 EXPOSURE TO FUNGUS 1 0.0047
58 EXPOSURE VIA INHALATION 1 0.0046
59 SICKLE CELL DISEASE 2 0.0043
60 INTENTIONAL DEVICE MISUSE 19 0.0043
61 DEVICE DISPENSING ERROR 5 0.0042
62 ENVIRONMENTAL EXPOSURE 1 0.0042
63 HYPERGAMMAGLOBULINAEMIA 2 0.0041
64 CHEYNE-STOKES RESPIRATION 1 0.0040
65 KERATOSIS PILARIS 1 0.0040
66 GINGIVAL EROSION 1 0.0039
67 PRODUCT KNOWLEDGE DEFICIT 3 0.0038
68 DEVICE DEFECTIVE 66 0.0038
69 WRONG TECHNIQUE IN DEVICE USAGE PROCESS 168 0.0036
70 CHOLESTEATOMA 1 0.0036
71 EAR INFLAMMATION 1 0.0035
72 OBSTRUCTIVE SLEEP APNOEA SYNDROME 5 0.0034
73 DOSE CALCULATION ERROR 2 0.0034
74 TEETHING 1 0.0033
75 PRODUCT AFTER TASTE 3 0.0031
76 OESOPHAGEAL CANCER METASTATIC 1 0.0031
77 CENTRAL SLEEP APNOEA SYNDROME 1 0.0031
78 ACUTE LEFT VENTRICULAR FAILURE 2 0.0030
79 OPHTHALMIC MIGRAINE 2 0.0029
80 HEART RATE 1 0.0029
81 MAST CELL ACTIVATION SYNDROME 4 0.0028
82 FUNGAL TEST POSITIVE 1 0.0028
83 FACIAL DISCOMFORT 2 0.0028
84 DEVICE INEFFECTIVE 3 0.0028
85 LARYNGEAL DISORDER 2 0.0028
86 MIXED ANXIETY AND DEPRESSIVE DISORDER 1 0.0027
87 KERATOCONUS 1 0.0027
88 POLYCYSTIC OVARIAN SYNDROME 1 0.0026
89 TOTAL LUNG CAPACITY ABNORMAL 1 0.0026
90 FAT TISSUE DECREASED 1 0.0026
91 DEVICE MALFUNCTION 179 0.0025
92 HUMIDITY INTOLERANCE 1 0.0025
93 RAPID EYE MOVEMENT SLEEP BEHAVIOUR DISORDER 1 0.0025
94 CLUBBING 1 0.0025
95 INFUSION SITE WARMTH 3 0.0024
96 MOUTH BREATHING 1 0.0023
97 GINGIVAL BLISTER 1 0.0023
98 REFLUX LARYNGITIS 1 0.0023
99 EYELID INFECTION 1 0.0023
100 INFUSION SITE SCAR 1 0.0023
101 ALLERGY TO PLANTS 1 0.0022
102 INFUSION SITE RASH 3 0.0022
103 ESSENTIAL HYPERTENSION 4 0.0022
104 PELVIC INFECTION 1 0.0022
105 MAGNESIUM DEFICIENCY 1 0.0021
106 IMMUNODEFICIENCY COMMON VARIABLE 1 0.0020
107 ROOT CANAL INFECTION 1 0.0020
108 RESPIRATORY TRACT INFECTION BACTERIAL 1 0.0020
109 INJURY CORNEAL 1 0.0019
110 SINUSITIS BACTERIAL 2 0.0019
111 POOR QUALITY DEVICE USED 19 0.0019
112 ALLERGY TO ANIMAL 2 0.0019
113 CHRONIC SINUSITIS 7 0.0019
114 OESOPHAGEAL FOOD IMPACTION 1 0.0018
115 SUSPECTED PRODUCT TAMPERING 1 0.0018
116 CATHETER SITE DISCHARGE 2 0.0018
117 CATHETER SITE INFLAMMATION 1 0.0018
118 SOFT TISSUE SWELLING 1 0.0018
119 ASTHMA 197 0.0017
120 SINUS POLYP 1 0.0017
121 PHYSICAL PRODUCT LABEL ISSUE 2 0.0017
122 ARTHRITIS REACTIVE 1 0.0016
123 HYPERAESTHESIA TEETH 2 0.0016
124 INFUSION SITE PRURITUS 5 0.0016
125 NOCTURNAL DYSPNOEA 2 0.0016
126 LIP HAEMORRHAGE 2 0.0016
127 INFUSION SITE IRRITATION 2 0.0016
128 PAROTID GLAND ENLARGEMENT 1 0.0015
129 SPUTUM PURULENT 1 0.0015
130 CEREBRAL SMALL VESSEL ISCHAEMIC DISEASE 1 0.0015
131 POST PROCEDURAL DISCHARGE 1 0.0015
132 EMERGENCY CARE EXAMINATION 1 0.0015
133 COMPUTERISED TOMOGRAM THORAX ABNORMAL 1 0.0015
134 RHONCHI 2 0.0014
135 FOREARM FRACTURE 1 0.0014
136 PARASOMNIA 1 0.0014
137 ANTIBODY TEST ABNORMAL 1 0.0014
138 DYSPNOEA PAROXYSMAL NOCTURNAL 1 0.0014
139 FIBROCYSTIC BREAST DISEASE 1 0.0014
140 INFUSION SITE INDURATION 2 0.0013
141 RHINITIS ALLERGIC 6 0.0013
142 LIMB CRUSHING INJURY 1 0.0013
143 BRONCHITIS BACTERIAL 1 0.0013
144 ORAL MUCOSAL ERUPTION 2 0.0013
145 PRODUCT INEFFECTIVE 1 0.0013
146 POST-TRAUMATIC NECK SYNDROME 1 0.0012
147 ELECTROCARDIOGRAM ST SEGMENT ABNORMAL 1 0.0012
148 PERITONSILLAR ABSCESS 1 0.0012
149 ADRENAL SUPPRESSION 1 0.0012
150 PERIORBITAL PAIN 1 0.0012
151 PRODUCT LABEL ISSUE 8 0.0012
152 MYCOTIC ALLERGY 1 0.0012
153 LUNG HYPERINFLATION 1 0.0012
154 SOLILOQUY 1 0.0012
155 RECALLED PRODUCT 2 0.0012
156 INFUSION SITE DISCHARGE 2 0.0011
157 HILAR LYMPHADENOPATHY 1 0.0011
158 DRUG DOSE OMISSION BY DEVICE 88 0.0011
159 BLOOD ALBUMIN INCREASED 1 0.0011
160 OROPHARYNGEAL CANDIDIASIS 1 0.0011
161 INJECTION SITE DRYNESS 1 0.0011
162 MUSCLE SWELLING 1 0.0011
163 PHARYNGEAL HYPOAESTHESIA 1 0.0011
164 SEASONAL ALLERGY 15 0.0011
165 PARANASAL SINUS DISCOMFORT 4 0.0011
166 HYPERMETROPIA 1 0.0011
167 ARNOLD-CHIARI MALFORMATION 1 0.0010
168 INSURANCE ISSUE 16 0.0010
169 INFUSION SITE NODULE 1 0.0010
170 BLADDER CATHETERISATION 1 0.0010
171 CORRECTIVE LENS USER 1 0.0010
172 MULTIPLE ALLERGIES 8 0.0010
173 DUST ALLERGY 1 0.0010
174 NASAL POLYPS 5 0.0010
175 DRUG EFFECT LESS THAN EXPECTED 15 0.0010
176 INTENTIONAL MEDICAL DEVICE REMOVAL BY PATIENT 1 0.0010
177 BRAIN HYPOXIA 1 0.0010
178 POLYCYTHAEMIA 2 0.0010
179 RESPIRATORY TRACT IRRITATION 1 0.0010
180 INCORRECT DRUG ADMINISTRATION RATE 4 0.0009
181 INFUSION SITE BRUISING 2 0.0009
182 PRODUCT LOT NUMBER ISSUE 2 0.0009
183 PULMONARY SARCOIDOSIS 1 0.0009
184 PRODUCT DOSE OMISSION ISSUE 261 0.0009
185 READING DISORDER 2 0.0009
186 CARBON DIOXIDE DECREASED 1 0.0009
187 DYSLEXIA 1 0.0009
188 THERAPEUTIC PRODUCT EFFECT INCREASED 1 0.0009
189 PRURITUS ALLERGIC 1 0.0009
190 MULTIMORBIDITY 1 0.0008
191 CHRONIC RESPIRATORY FAILURE 1 0.0008
192 BLOOD IMMUNOGLOBULIN E INCREASED 2 0.0008
193 EYELID SKIN DRYNESS 1 0.0008
194 ASTHMATIC CRISIS 3 0.0008
195 INCORRECT DOSAGE ADMINISTERED 4 0.0008
196 TOOTH EROSION 1 0.0008
197 NASAL PRURITUS 1 0.0008
198 EYELID IRRITATION 2 0.0008
199 FRACTURED COCCYX 1 0.0008
200 DEVICE FAILURE 12 0.0008
201 ENDOCRINE DISORDER 1 0.0008
202 LIPOMA 2 0.0008
203 LIP INJURY 1 0.0008
204 EPSTEIN-BARR VIRUS INFECTION REACTIVATION 1 0.0008
205 NASAL DISORDER 2 0.0008
206 BRONCHIECTASIS 5 0.0007
207 WHEEZING 44 0.0007
208 POSTURAL ORTHOSTATIC TACHYCARDIA SYNDROME 1 0.0007
209 OFF LABEL USE OF DEVICE 1 0.0007
210 MIGRAINE WITH AURA 2 0.0007
211 CARBON DIOXIDE INCREASED 1 0.0007
212 EOSINOPHILIC OESOPHAGITIS 2 0.0007
213 PRODUCT DISPENSING ISSUE 3 0.0007
214 NONINFECTIVE GINGIVITIS 1 0.0007
215 AUTONOMIC NERVOUS SYSTEM IMBALANCE 2 0.0007
216 ORAL CANDIDIASIS 9 0.0007
217 GENERALISED ANXIETY DISORDER 1 0.0007
218 ANKLE OPERATION 1 0.0007
219 CONJUNCTIVITIS ALLERGIC 1 0.0007
220 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 134 0.0007
221 ORAL MUCOSAL EXFOLIATION 1 0.0007
222 EMERGENCY CARE 2 0.0007
223 MOUTH INJURY 1 0.0007
224 DECREASED ACTIVITY 7 0.0006
225 DAYDREAMING 1 0.0006
226 ORAL MUCOSAL ERYTHEMA 1 0.0006
227 EYE ALLERGY 1 0.0006
228 BRONCHIAL DISORDER 1 0.0006
229 UMBILICAL HERNIA 3 0.0006
230 SECRETION DISCHARGE 8 0.0006
231 RHINITIS 5 0.0006
232 ANTINUCLEAR ANTIBODY POSITIVE 2 0.0006
233 DYSPHONIA 36 0.0006
234 COSTOCHONDRITIS 1 0.0006
235 SHOULDER FRACTURE 1 0.0006
236 THERAPY CHANGE 6 0.0006
237 OXYGEN THERAPY 1 0.0006
238 BREATH SOUNDS ABNORMAL 3 0.0006
239 SPINAL CORD DISORDER 1 0.0006
240 PRODUCT PRESCRIBING ISSUE 13 0.0006
241 CANDIDA INFECTION 10 0.0006
242 SLEEP TALKING 1 0.0006
243 SLEEP DISORDER DUE TO A GENERAL MEDICAL CONDITION 10 0.0006
244 LAZINESS 1 0.0006
245 RESPIRATION ABNORMAL 4 0.0006
246 TONGUE COATED 1 0.0006
247 SPINAL CORD INJURY 1 0.0006
248 LACK OF INJECTION SITE ROTATION 1 0.0006
249 HANGOVER 2 0.0006
250 DEVICE OCCLUSION 8 0.0006
251 FEAR OF DISEASE 1 0.0006
252 INTRA-ABDOMINAL FLUID COLLECTION 1 0.0006
253 IMPAIRED QUALITY OF LIFE 8 0.0006
254 NASAL OEDEMA 1 0.0006
255 THROMBOCYTOSIS 2 0.0005
256 PRODUCTIVE COUGH 26 0.0005
257 AURA 1 0.0005
258 THROAT CLEARING 2 0.0005
259 SNORING 2 0.0005
260 DEVICE ISSUE 47 0.0005
261 THYROID MASS 2 0.0005
262 ADRENAL DISORDER 1 0.0005
263 PATIENT DISSATISFACTION WITH TREATMENT 1 0.0005
264 FOOD ALLERGY 4 0.0005
265 CONCUSSION 4 0.0005
266 RHINOVIRUS INFECTION 2 0.0005
267 DEVICE INFORMATION OUTPUT ISSUE 4 0.0005
268 NASAL SEPTUM DEVIATION 1 0.0005
269 ANORECTAL DISORDER 1 0.0005
270 NIPPLE PAIN 1 0.0005
271 UPPER-AIRWAY COUGH SYNDROME 4 0.0005
272 LIVEDO RETICULARIS 1 0.0005
273 ILLNESS 49 0.0005
274 INFUSION SITE ERYTHEMA 4 0.0005
275 STAPHYLOCOCCUS TEST POSITIVE 1 0.0005
276 EYE CONTUSION 1 0.0005
277 PHARYNGEAL ERYTHEMA 1 0.0005
278 CATHETER SITE ERYTHEMA 1 0.0005
279 INFUSION SITE PAIN 6 0.0005
280 SPUTUM INCREASED 1 0.0005
281 PRODUCT COMMUNICATION ISSUE 4 0.0005
282 CALCINOSIS 1 0.0004
283 PRODUCT USE ISSUE 84 0.0004
284 BRAIN FOG 7 0.0004
285 BRONCHITIS 33 0.0004
286 FEAR OF DEATH 1 0.0004
287 IRON DEFICIENCY 2 0.0004
288 SINUS CONGESTION 6 0.0004
289 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 23 0.0004
290 LICHEN PLANUS 1 0.0004
291 IMPLANT SITE INFECTION 1 0.0004
292 SINUS PAIN 1 0.0004
293 SKIN ABRASION 2 0.0004
294 PRODUCT PACKAGING ISSUE 4 0.0004
295 ENDOMETRIOSIS 2 0.0004
296 OXYGEN CONSUMPTION INCREASED 1 0.0004
297 INCORRECT DOSE ADMINISTERED 95 0.0004
298 PULSE ABNORMAL 1 0.0004
299 BRONCHITIS CHRONIC 1 0.0004
300 HAEMATOLOGICAL INFECTION 1 0.0004
301 ARTHROPOD BITE 3 0.0004
302 BLOOD PRESSURE SYSTOLIC ABNORMAL 1 0.0004
303 DEVICE INFUSION ISSUE 1 0.0004
304 SUFFOCATION FEELING 1 0.0004
305 DEVICE USE ERROR 14 0.0004
306 CATHETER SITE HAEMORRHAGE 1 0.0004
307 PRODUCT CONTAMINATION PHYSICAL 1 0.0004
308 COUGH 110 0.0004
309 ABDOMINAL INFECTION 1 0.0004
310 DRUG DELIVERY SYSTEM MALFUNCTION 2 0.0004
311 INCREASED BRONCHIAL SECRETION 1 0.0004
312 AORTIC ARTERIOSCLEROSIS 1 0.0004
313 PRODUCT DOSE OMISSION IN ERROR 11 0.0004
314 DRUG TITRATION ERROR 1 0.0004
315 EXPOSURE VIA SKIN CONTACT 10 0.0004
316 CATHETER SITE PAIN 1 0.0004
317 PULMONARY CONGESTION 5 0.0004
318 GINGIVAL PAIN 3 0.0004
319 OBESITY 6 0.0004
320 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 1 0.0004
321 OVERWEIGHT 2 0.0004
322 DYSPNOEA EXERTIONAL 14 0.0004
323 FRUSTRATION TOLERANCE DECREASED 3 0.0004
324 HICCUPS 3 0.0004
325 ORAL FUNGAL INFECTION 1 0.0004
326 DEVICE MECHANICAL ISSUE 5 0.0004
327 TENOSYNOVITIS 1 0.0004
328 PLEURITIC PAIN 1 0.0004
329 STREPTOCOCCAL INFECTION 2 0.0004
330 TRICHORRHEXIS 1 0.0004
331 APHONIA 5 0.0004
332 OXYGEN SATURATION ABNORMAL 1 0.0004
333 CHEST DISCOMFORT 36 0.0004
334 EXERCISE TOLERANCE DECREASED 2 0.0003
335 HYPERTONIC BLADDER 1 0.0003
336 DYSPNOEA AT REST 1 0.0003
337 PRODUCT LABEL CONFUSION 2 0.0003
338 PULMONARY PAIN 1 0.0003
339 LUMBAR SPINAL STENOSIS 1 0.0003
340 SINUS HEADACHE 2 0.0003
341 PULMONARY MASS 5 0.0003
342 INFUSION SITE REACTION 1 0.0003
343 SYMPTOM RECURRENCE 2 0.0003
344 HYPERCAPNIA 1 0.0003
345 INJECTION SITE VESICLES 2 0.0003
346 KERATITIS 1 0.0003
347 MASTICATION DISORDER 1 0.0003
348 DYSAESTHESIA 1 0.0003
349 DYSPNOEA 183 0.0003
350 FAMILY STRESS 1 0.0003
351 EYELIDS PRURITUS 1 0.0003
352 PRE-EXISTING CONDITION IMPROVED 2 0.0003
353 NASAL DRYNESS 2 0.0003
354 INFUSION SITE SWELLING 2 0.0003
355 PHOTOPSIA 2 0.0003
356 SPUTUM DISCOLOURED 3 0.0003
357 POLYMYALGIA RHEUMATICA 1 0.0003
358 RESPIRATORY TRACT CONGESTION 5 0.0003
359 SNEEZING 7 0.0003
360 SKIN EROSION 1 0.0003
361 LOOSE TOOTH 1 0.0003
362 RESPIRATORY TRACT INFECTION 8 0.0003
363 SOMNAMBULISM 2 0.0003
364 INFUSION SITE HAEMORRHAGE 1 0.0003
365 NEAR DEATH EXPERIENCE 1 0.0003
366 OTITIS MEDIA 1 0.0003
367 SKIN INJURY 1 0.0003
368 DRY EYE 15 0.0003
369 LYME DISEASE 1 0.0003
370 POST-TRAUMATIC STRESS DISORDER 2 0.0003
371 PRODUCT ADMINISTRATION ERROR 6 0.0003
372 DEVICE BREAKAGE 12 0.0003
373 DRY THROAT 3 0.0003
374 MATERNAL EXPOSURE BEFORE PREGNANCY 2 0.0003
375 TEMPERATURE INTOLERANCE 3 0.0003
376 NASAL CONGESTION 17 0.0003
377 LYMPHOEDEMA 2 0.0003
378 GRANULOMA 1 0.0003
379 EAR PRURITUS 1 0.0003
380 MUSCLE CONTRACTIONS INVOLUNTARY 1 0.0003
381 BRONCHIOLITIS 1 0.0003
382 GLOSSITIS 1 0.0003
383 FIBRIN D DIMER INCREASED 1 0.0003
384 PRODUCT CONTAMINATION 1 0.0003
385 OROPHARYNGEAL PAIN 26 0.0003
386 BRONCHOSPASM 4 0.0003
387 SKIN WEEPING 1 0.0003
388 INTERCEPTED PRODUCT STORAGE ERROR 1 0.0003
389 PANIC REACTION 2 0.0003
390 SCLERODERMA 1 0.0003
391 EYE DISORDER 9 0.0003
392 SENSITIVE SKIN 2 0.0003
393 PSYCHIATRIC SYMPTOM 2 0.0003
394 OBSTRUCTIVE AIRWAYS DISORDER 3 0.0003
395 SKIN INFECTION 3 0.0003
396 PRODUCT STORAGE ISSUE 1 0.0003
397 FACE INJURY 1 0.0003
398 PULMONARY FIBROSIS 5 0.0003
399 PANIC DISORDER 1 0.0003
400 PRODUCT ADMINISTRATION INTERRUPTED 2 0.0003
401 PNEUMONIA FUNGAL 1 0.0003
402 POLYDIPSIA 1 0.0003
403 OBSTRUCTION 1 0.0003
404 CREATININE RENAL CLEARANCE DECREASED 1 0.0002
405 INTRACRANIAL ANEURYSM 1 0.0002
406 STENT PLACEMENT 2 0.0002
407 SPINAL FUSION SURGERY 1 0.0002
408 TASTE DISORDER 5 0.0002
409 GOITRE 1 0.0002
410 DEMYELINATION 1 0.0002
411 INJECTION SITE WARMTH 5 0.0002
412 UPPER RESPIRATORY TRACT INFECTION 11 0.0002
413 BUNDLE BRANCH BLOCK LEFT 1 0.0002
414 TONGUE DISCOMFORT 1 0.0002
415 CARDIAC FAILURE CHRONIC 1 0.0002
416 VITAMIN D DECREASED 2 0.0002
417 SHOULDER OPERATION 1 0.0002
418 PSEUDOMONAS INFECTION 2 0.0002
419 RHINORRHOEA 15 0.0002
420 HORDEOLUM 1 0.0002
421 CHAPPED LIPS 1 0.0002
422 BONE CANCER 1 0.0002
423 RESPIRATORY SYNCYTIAL VIRUS INFECTION 2 0.0002
424 PULMONARY FUNCTION TEST DECREASED 1 0.0002
425 GRIP STRENGTH DECREASED 2 0.0002
426 GASTROINTESTINAL INFECTION 2 0.0002
427 OROPHARYNGEAL DISCOMFORT 2 0.0002
428 IMPAIRED GASTRIC EMPTYING 3 0.0002
429 PRODUCT AVAILABILITY ISSUE 5 0.0002
430 ABDOMINAL HERNIA 1 0.0002
431 INJECTION SITE PAPULE 1 0.0002
432 EAR DISORDER 1 0.0002
433 LUMBAR VERTEBRAL FRACTURE 1 0.0002
434 RESPIRATORY DISTRESS 6 0.0002
435 EYE OPERATION 1 0.0002
436 ROSACEA 1 0.0002
437 MIDDLE INSOMNIA 4 0.0002
438 INTENTIONAL DOSE OMISSION 6 0.0002
439 FEELING JITTERY 4 0.0002
440 SLEEP APNOEA SYNDROME 4 0.0002
441 TUMOUR MARKER INCREASED 1 0.0002
442 DEVICE LEAKAGE 9 0.0002
443 NEEDLE ISSUE 6 0.0002
444 VITAMIN D DEFICIENCY 2 0.0002
445 HORMONE LEVEL ABNORMAL 1 0.0002
446 ORAL HERPES 4 0.0002
447 SINUSITIS 21 0.0002
448 HAEMORRHOIDAL HAEMORRHAGE 1 0.0002
449 SKIN FISSURES 4 0.0002
450 KIDNEY INFECTION 4 0.0002
451 FOOT OPERATION 1 0.0002
452 SINUS DISORDER 4 0.0002
453 IMMUNODEFICIENCY 3 0.0002
454 PRODUCT COMPLAINT 5 0.0002
455 INJECTION SITE RASH 6 0.0002
456 NEUTROPHIL COUNT INCREASED 2 0.0002
457 EUPHORIC MOOD 2 0.0002
458 VENTRICULAR EXTRASYSTOLES 2 0.0002
459 DIPLOPIA 5 0.0002
460 INJECTION SITE DISCOMFORT 2 0.0002
461 POLYARTHRITIS 1 0.0002
462 HEAD INJURY 6 0.0002
463 JOINT INJURY 4 0.0002
464 FOOD POISONING 1 0.0002
465 HEREDITARY ANGIOEDEMA 2 0.0002
466 HYPOACUSIS 8 0.0002
467 PRODUCT RESIDUE PRESENT 1 0.0002
468 ERYTHEMA OF EYELID 1 0.0002
469 SKIN LACERATION 2 0.0002
470 INTENTIONAL PRODUCT MISUSE 16 0.0002
471 PHOTOSENSITIVITY REACTION 3 0.0002
472 TOOTH FRACTURE 2 0.0002
473 HEART RATE ABNORMAL 1 0.0002
474 ACUTE PULMONARY OEDEMA 1 0.0002
475 OCULAR DISCOMFORT 2 0.0002
476 MULTIPLE USE OF SINGLE-USE PRODUCT 1 0.0002
477 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 6 0.0002
478 PERIORBITAL SWELLING 1 0.0002
479 CHOLECYSTECTOMY 2 0.0002
480 INTERNAL HAEMORRHAGE 2 0.0002
481 VISION BLURRED 24 0.0002
482 HYPERVENTILATION 1 0.0002
483 SKIN WARM 1 0.0002
484 SPEECH DISORDER 9 0.0002
485 HYPERCHLORHYDRIA 1 0.0002
486 INJECTION SITE SWELLING 13 0.0002
487 CATARACT OPERATION 1 0.0002
488 PLEURISY 1 0.0002
489 THIRST 3 0.0002
490 ODYNOPHAGIA 1 0.0002
491 ACCIDENT 2 0.0002
492 HYPERLIPIDAEMIA 2 0.0002
493 HYPERSENSITIVITY 31 0.0002
494 GASTROENTERITIS VIRAL 3 0.0002
495 TYPE 1 DIABETES MELLITUS 1 0.0002
496 TOOTHACHE 3 0.0002
497 ARTHRITIS 13 0.0002
498 NOCTURIA 2 0.0002
499 INGUINAL HERNIA 1 0.0002
500 PRESCRIPTION DRUG USED WITHOUT A PRESCRIPTION 1 0.0002
501 ILEUS 2 0.0002
502 INFUSION SITE EXTRAVASATION 1 0.0002
503 AGEUSIA 4 0.0002
504 EPSTEIN-BARR VIRUS INFECTION 1 0.0002
505 PHOTOPHOBIA 3 0.0002
506 SWELLING OF EYELID 1 0.0002
507 OVERDOSE 34 0.0002
508 FOREIGN BODY SENSATION IN EYES 1 0.0002
509 DEVICE DEPLOYMENT ISSUE 2 0.0002
510 THROAT IRRITATION 7 0.0002
511 GLAUCOMA 3 0.0002
512 HERNIA 3 0.0002
513 HIATUS HERNIA 2 0.0002
514 EAR PAIN 3 0.0002
515 CHOKING 3 0.0002
516 VISUAL IMPAIRMENT 19 0.0002
517 NERVOUSNESS 8 0.0002
518 PRODUCT PREPARATION ISSUE 1 0.0002
519 ASPERGILLUS INFECTION 1 0.0002
520 BLOOD PRESSURE ABNORMAL 3 0.0002
521 APPETITE DISORDER 1 0.0002
522 ADVERSE REACTION 2 0.0002
523 THERAPEUTIC RESPONSE SHORTENED 5 0.0002
524 EAR INFECTION 4 0.0002
525 EYE HAEMORRHAGE 2 0.0001
526 INJECTION SITE PRURITUS 10 0.0001
527 EYE PRURITUS 5 0.0001
528 EXTRA DOSE ADMINISTERED 6 0.0001
529 POSTOPERATIVE WOUND INFECTION 1 0.0001
530 PRODUCT TASTE ABNORMAL 2 0.0001
531 BLINDNESS 6 0.0001
532 GINGIVAL BLEEDING 2 0.0001
533 ONYCHOCLASIS 1 0.0001
534 ABNORMAL DREAMS 4 0.0001
535 ANAPHYLACTIC REACTION 8 0.0001
536 POLLAKIURIA 6 0.0001
537 HYPERTRANSAMINASAEMIA 1 0.0001
538 EXTRASYSTOLES 1 0.0001
539 LUNG DISORDER 7 0.0001
540 CARPAL TUNNEL SYNDROME 2 0.0001
541 HAND FRACTURE 1 0.0001
542 NASOPHARYNGITIS 26 0.0001
543 THERMAL BURN 1 0.0001
544 RETCHING 3 0.0001
545 PRODUCT SUPPLY ISSUE 1 0.0001
546 PARAESTHESIA ORAL 2 0.0001
547 ANOSMIA 2 0.0001
548 LIQUID PRODUCT PHYSICAL ISSUE 1 0.0001
549 GASTROENTERITIS 2 0.0001
550 MAJOR DEPRESSION 1 0.0001
551 ORAL DISORDER 1 0.0001
552 MOUTH HAEMORRHAGE 1 0.0001
553 THERAPY CESSATION 7 0.0001
554 LOWER GASTROINTESTINAL HAEMORRHAGE 1 0.0001
555 PULMONARY OEDEMA 6 0.0001
556 DERMATITIS ATOPIC 7 0.0001
557 PAROSMIA 1 0.0001
558 HIP ARTHROPLASTY 2 0.0001
559 BOWEL MOVEMENT IRREGULARITY 1 0.0001
560 DEVICE PHYSICAL PROPERTY ISSUE 1 0.0001
561 PNEUMONIA 42 0.0001
562 ATRIOVENTRICULAR BLOCK 1 0.0001
563 MUSCULOSKELETAL CHEST PAIN 2 0.0001
564 ANKLE FRACTURE 2 0.0001
565 TENDONITIS 2 0.0001
566 APHTHOUS ULCER 1 0.0001
567 BURNING SENSATION 9 0.0001
568 SWELLING 12 0.0001
569 THERAPY PARTIAL RESPONDER 2 0.0001
570 PULMONARY HAEMORRHAGE 1 0.0001
571 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 23 0.0001
572 PRODUCT USE COMPLAINT 2 0.0001
573 NASAL DISCOMFORT 1 0.0001
574 PNEUMOTHORAX 2 0.0001
575 RENAL CYST 1 0.0001
576 PRODUCT USE IN UNAPPROVED INDICATION 31 0.0001
577 OBSESSIVE-COMPULSIVE DISORDER 1 0.0001
578 SENSORY LOSS 1 0.0001
579 LOCALISED INFECTION 3 0.0001
580 DRY MOUTH 10 0.0001
581 BACK DISORDER 2 0.0001
582 POST PROCEDURAL INFECTION 1 0.0001
583 ASPHYXIA 1 0.0001
584 INJECTION SITE URTICARIA 3 0.0001
585 MENSTRUAL DISORDER 1 0.0001
586 VIRAL INFECTION 4 0.0001
587 FUNGAL INFECTION 4 0.0001
588 BONE PAIN 7 0.0001
589 PERICARDITIS 2 0.0001
590 CHEST PAIN 22 0.0001
591 CATARACT 7 0.0001
592 INJECTION SITE PAIN 36 0.0001
593 SCAR 2 0.0001
594 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 2 0.0001
595 CARDIAC OPERATION 1 0.0001
596 NIGHTMARE 4 0.0001
597 MUSCLE STRAIN 1 0.0001
598 CARDIAC MURMUR 1 0.0001
599 RASH MACULAR 4 0.0001
600 NAIL DISORDER 1 0.0001
601 FEELING HOT 7 0.0001
602 EOSINOPHILIA 2 0.0001
603 SPINAL OSTEOARTHRITIS 1 0.0001
604 HYPOXIA 4 0.0001
605 IMMUNOSUPPRESSION 1 0.0001
606 SLEEP DISORDER 8 0.0001
607 LUNG INFILTRATION 1 0.0001
608 HEAD DISCOMFORT 2 0.0001
609 INJECTION SITE ERYTHEMA 14 0.0001
610 GOUT 2 0.0001
611 LIMB INJURY 3 0.0001
612 PNEUMONITIS 3 0.0001
613 HIDRADENITIS 1 0.0001
614 INCREASED TENDENCY TO BRUISE 1 0.0001
615 INTERVERTEBRAL DISC DEGENERATION 1 0.0001
616 THINKING ABNORMAL 2 0.0001
617 APPENDICITIS 1 0.0001
618 DIARRHOEA HAEMORRHAGIC 1 0.0001
619 OXYGEN SATURATION DECREASED 6 0.0001
620 ACCIDENTAL EXPOSURE TO PRODUCT 11 0.0001
621 FLANK PAIN 1 0.0001
622 EYE PAIN 6 0.0001
623 DYSARTHRIA 4 0.0001
624 ARTERIOSCLEROSIS 1 0.0001
625 SQUAMOUS CELL CARCINOMA 1 0.0001
626 BLOOD URINE PRESENT 2 0.0001
627 EYE INFLAMMATION 1 0.0001
628 MIGRAINE 10 0.0001
629 EYE IRRITATION 6 0.0001
630 LOWER LIMB FRACTURE 2 0.0001
631 DRUG INEFFECTIVE 137 0.0001
632 ATELECTASIS 1 0.0001
633 PRESCRIBED OVERDOSE 2 0.0001
634 COVID-19 18 0.0001
635 DECREASED IMMUNE RESPONSIVENESS 1 0.0001
636 HEPATOMEGALY 1 0.0001
637 URTICARIA 17 0.0001
638 DISABILITY 2 0.0001
639 LIGAMENT SPRAIN 1 0.0001
640 RESPIRATORY DISORDER 3 0.0001
641 SPINAL FRACTURE 2 0.0001
642 BLOOD POTASSIUM DECREASED 3 0.0001
643 BRAIN INJURY 1 0.0001
644 GASTROOESOPHAGEAL REFLUX DISEASE 8 0.0001
645 EMPHYSEMA 1 0.0001
646 THERAPEUTIC RESPONSE DECREASED 6 0.0001
647 STOMATITIS 6 0.0001
648 DISCOMFORT 6 0.0001
649 TOOTH ABSCESS 1 0.0001
650 INJURY ASSOCIATED WITH DEVICE 2 0.0001
651 BODY TEMPERATURE INCREASED 2 0.0001
652 INITIAL INSOMNIA 1 0.0001
653 EAR DISCOMFORT 1 0.0001
654 RIB FRACTURE 2 0.0001
655 INFLAMMATION 5 0.0001
656 POOR VENOUS ACCESS 1 0.0001
657 EYE DISCHARGE 1 0.0001
658 SWOLLEN TONGUE 3 0.0001
659 PULMONARY HYPERTENSION 2 0.0001
660 KNEE ARTHROPLASTY 2 0.0001
661 DYSPHAGIA 9 0.0001
662 SCRATCH 1 0.0001
663 JOINT DISLOCATION 1 0.0001
664 FULL BLOOD COUNT ABNORMAL 1 0.0001
665 CLOSTRIDIUM DIFFICILE COLITIS 1 0.0001
666 MOOD SWINGS 3 0.0001
667 MYALGIA 16 0.0001
668 EATING DISORDER 2 0.0001
669 BREAST PAIN 1 0.0001
670 IMPAIRED WORK ABILITY 2 0.0001
671 ATRIAL FIBRILLATION 9 0.0001
672 PHARYNGITIS STREPTOCOCCAL 1 0.0001
673 PRODUCT DISPENSING ERROR 2 0.0001
674 OESOPHAGITIS 1 0.0001
675 STAPHYLOCOCCAL INFECTION 3 0.0001
676 HEADACHE 57 0.0001
677 INJECTION SITE NODULE 1 0.0001
678 DEVICE DIFFICULT TO USE 6 0.0001
679 DENTAL CARIES 1 0.0001
680 RED BLOOD CELL SEDIMENTATION RATE INCREASED 1 0.0001
681 MEDICATION ERROR 5 0.0001
682 GAIT INABILITY 3 0.0001
683 NECK PAIN 5 0.0001
684 GASTROINTESTINAL DISORDER 8 0.0001
685 TYPE 2 DIABETES MELLITUS 3 0.0001
686 ARTHRALGIA 37 0.0001
687 EYE INFECTION 1 0.0001
688 REBOUND EFFECT 1 0.0001
689 MITRAL VALVE INCOMPETENCE 1 0.0001
690 URINARY TRACT INFECTION 15 0.0001
691 INJECTION SITE BRUISING 7 0.0001
692 DERMATITIS CONTACT 1 0.0001
693 SCAB 1 0.0001
694 MICTURITION URGENCY 1 0.0001
695 PERICARDIAL EFFUSION 2 0.0001
696 ELECTROLYTE IMBALANCE 1 0.0001
697 CARDIAC DISORDER 8 0.0001
698 PRODUCT PRESCRIBING ERROR 2 0.0001
699 MACULAR DEGENERATION 1 0.0001
700 FEELING ABNORMAL 20 0.0001
701 BLOOD GLUCOSE DECREASED 4 0.0001
702 THYROID CANCER 1 0.0001
703 SKIN EXFOLIATION 7 0.0001
704 JOINT SWELLING 10 0.0001
705 NO ADVERSE EVENT 15 0.0001
706 BURSITIS 1 0.0001
707 ACCIDENTAL OVERDOSE 3 0.0001
708 BACK PAIN 19 0.0001
709 RESPIRATORY DEPRESSION 1 0.0001
710 CARDIOMEGALY 1 0.0001
711 INJECTION SITE MASS 3 0.0001
712 BALANCE DISORDER 7 0.0001
713 HEART RATE INCREASED 8 0.0001
714 PHARYNGITIS 1 0.0001
715 CYST 1 0.0001
716 MEMORY IMPAIRMENT 11 0.0001
717 INJECTION SITE DISCOLOURATION 1 0.0001
718 CELLULITIS 4 0.0001
719 MUSCLE ATROPHY 1 0.0001
720 INJECTION SITE INDURATION 1 0.0001
721 NODULE 1 0.0001
722 ECZEMA 4 0.0001
723 JOINT STIFFNESS 2 0.0001
724 GASTRITIS 2 0.0001
725 INFECTION 11 0.0001
726 ANKYLOSING SPONDYLITIS 1 0.0001
727 FATIGUE 59 0.0001
728 CONDITION AGGRAVATED 23 0.0001
729 DYSMENORRHOEA 1 0.0001
730 BLOOD PRESSURE DECREASED 5 0.0001
731 DRY SKIN 10 0.0001
732 CARDIAC FAILURE CONGESTIVE 6 0.0001
733 QUALITY OF LIFE DECREASED 1 0.0001
734 FEAR 2 0.0001
735 THROAT TIGHTNESS 2 0.0001
736 TACHYPNOEA 1 0.0001
737 CORONARY ARTERY OCCLUSION 1 0.0001
738 PROSTATIC SPECIFIC ANTIGEN INCREASED 1 0.0001
739 DIVERTICULITIS 2 0.0001
740 HUNGER 1 0.0001
741 ROAD TRAFFIC ACCIDENT 3 0.0001
742 HAEMOPTYSIS 2 0.0001
743 MASS 1 0.0001
744 SKIN REACTION 1 0.0001
745 PAIN IN JAW 2 0.0001
746 PARALYSIS 1 0.0001
747 HYPOKINESIA 1 0.0001
748 FLUSHING 7 0.0001
749 GAIT DISTURBANCE 13 0.0001
750 CARDIOMYOPATHY 1 0.0001
751 URINARY INCONTINENCE 2 0.0001
752 SKIN HAEMORRHAGE 1 0.0001
753 THERAPEUTIC RESPONSE UNEXPECTED 3 0.0001
754 EPISTAXIS 5 0.0001
755 HYPOAESTHESIA ORAL 1 0.0001
756 TREMOR 11 0.0001
757 DIZZINESS 33 0.0001
758 FALL 22 0.0001
759 CORONARY ARTERY DISEASE 2 0.0001
760 LOWER RESPIRATORY TRACT INFECTION 3 0.0001
761 OSTEOPENIA 1 0.0001
762 DIABETES MELLITUS 5 0.0001
763 FEMUR FRACTURE 2 0.0001
764 SOMNOLENCE 13 0.0001
765 MALAISE 28 0.0001
766 CYANOSIS 1 0.0001
767 ULCER 1 0.0001
768 CYSTITIS 2 0.0001
769 SCIATICA 1 0.0001
770 HYPOTHYROIDISM 2 0.0001
771 LOSS OF PERSONAL INDEPENDENCE IN DAILY ACTIVITIES 3 0.0001
772 PRURITUS 24 0.0001
773 LOSS OF CONSCIOUSNESS 8 0.0001
774 CONTUSION 6 0.0001
775 BLOOD POTASSIUM INCREASED 1 0.0001
776 SWELLING FACE 4 0.0001
777 MANIA 1 0.0001
778 GENERALISED TONIC-CLONIC SEIZURE 1 0.0001
779 EXPIRED PRODUCT ADMINISTERED 2 0.0001
780 INSOMNIA 16 0.0001
781 LIP SWELLING 2 0.0001
782 COAGULOPATHY 1 0.0001
783 SYNCOPE 6 0.0001
784 NEOPLASM MALIGNANT 4 0.0001
785 PALPITATIONS 7 0.0001
786 CHILLS 7 0.0001
787 FACE OEDEMA 1 0.0001
788 TRANSIENT ISCHAEMIC ATTACK 2 0.0001
789 PRODUCT QUALITY ISSUE 8 0.0001
790 BLOOD PRESSURE INCREASED 9 0.0001
791 INJECTION SITE REACTION 4 0.0001
792 MUSCULOSKELETAL DISCOMFORT 1 0.0001
793 ABDOMINAL DISTENSION 6 0.0001
794 ORTHOSTATIC HYPOTENSION 1 0.0001
795 SYRINGE ISSUE 1 0.0001
796 INTENTIONAL PRODUCT USE ISSUE 5 0.0001
797 COLD SWEAT 1 0.0001
798 LYMPHOCYTE COUNT DECREASED 1 0.0001
799 TACHYCARDIA 5 0.0001
800 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 4 0.0001
801 THERAPY INTERRUPTED 4 0.0001
802 OSTEOMYELITIS 1 0.0001
803 PELVIC PAIN 1 0.0001
804 BONE DISORDER 1 0.0001
805 DYSURIA 2 0.0001
806 BLOOD GLUCOSE ABNORMAL 1 0.0001
807 SEPSIS 6 0.0001
808 ABDOMINAL DISCOMFORT 9 0.0001
809 BACTERIAL INFECTION 1 0.0001
810 HYPONATRAEMIA 3 0.0001
811 HEPATIC CIRRHOSIS 1 0.0001
812 FOOT FRACTURE 1 0.0001
813 CHRONIC KIDNEY DISEASE 4 0.0001
814 DEHYDRATION 7 0.0001
815 WHITE BLOOD CELL COUNT INCREASED 2 0.0001
816 POST PROCEDURAL COMPLICATION 1 0.0001
817 HYPERTENSION 11 0.0001
818 ERUCTATION 1 0.0001
819 SURGERY 3 0.0001
820 DYSPEPSIA 5 0.0001
821 PAIN 31 0.0001
822 HAEMATOCRIT DECREASED 1 0.0001
823 UPPER LIMB FRACTURE 1 0.0001
824 THROMBOSIS 4 0.0000
825 FULL BLOOD COUNT DECREASED 1 0.0000
826 PSORIATIC ARTHROPATHY 2 0.0000
827 WEIGHT INCREASED 11 0.0000
828 OFF LABEL USE 43 0.0000
829 PRODUCT PREPARATION ERROR 1 0.0000
830 LUNG NEOPLASM MALIGNANT 2 0.0000
831 ERYTHEMA 10 0.0000
832 ASTHENIA 18 0.0000
833 DERMATITIS 1 0.0000
834 OSTEOARTHRITIS 2 0.0000
835 IRRITABLE BOWEL SYNDROME 1 0.0000
836 LIVER FUNCTION TEST INCREASED 1 0.0000
837 POOR QUALITY SLEEP 1 0.0000
838 DEEP VEIN THROMBOSIS 3 0.0000
839 INCORRECT PRODUCT ADMINISTRATION DURATION 1 0.0000
840 MENTAL DISORDER 2 0.0000
841 RASH 20 0.0000
842 CLOSTRIDIUM DIFFICILE INFECTION 1 0.0000
843 PERIPHERAL SWELLING 7 0.0000
844 INFUSION RELATED REACTION 3 0.0000
845 ANGIOEDEMA 2 0.0000
846 COLITIS ULCERATIVE 2 0.0000
847 GLOSSODYNIA 1 0.0000
848 ORAL PAIN 1 0.0000
849 RASH PAPULAR 1 0.0000
850 THERAPY NON-RESPONDER 2 0.0000
851 ABDOMINAL PAIN UPPER 9 0.0000
852 NEPHROLITHIASIS 2 0.0000
853 HYPOKALAEMIA 2 0.0000
854 CONFUSIONAL STATE 7 0.0000
855 SEIZURE 5 0.0000
856 INJURY 3 0.0000
857 ANXIETY 12 0.0000
858 SKIN BURNING SENSATION 3 0.0000
859 MOBILITY DECREASED 3 0.0000
860 NAUSEA 33 0.0000
861 DIABETIC KETOACIDOSIS 1 0.0000
862 PRESYNCOPE 1 0.0000
863 NEURALGIA 1 0.0000
864 UNDERDOSE 3 0.0000
865 OEDEMA PERIPHERAL 5 0.0000
866 HALLUCINATION 3 0.0000
867 UNEVALUABLE EVENT 3 0.0000
868 ACNE 3 0.0000
869 DEPRESSION 9 0.0000
870 ABDOMINAL PAIN LOWER 1 0.0000
871 HAEMATEMESIS 1 0.0000
872 FLUID RETENTION 2 0.0000
873 HYPOPHAGIA 1 0.0000
874 ERECTILE DYSFUNCTION 1 0.0000
875 SKIN ULCER 1 0.0000
876 HAEMATOMA 1 0.0000
877 DEAFNESS 1 0.0000
878 MUSCLE SPASMS 7 0.0000
879 PARAESTHESIA 6 0.0000
880 DEPRESSED MOOD 2 0.0000
881 ASPARTATE AMINOTRANSFERASE INCREASED 2 0.0000
882 PAIN IN EXTREMITY 11 0.0000
883 BLOOD GLUCOSE INCREASED 7 0.0000
884 FREQUENT BOWEL MOVEMENTS 1 0.0000
885 RASH PRURITIC 2 0.0000
886 OEDEMA 2 0.0000
887 ANAEMIA 7 0.0000
888 SKIN LESION 1 0.0000
889 INFLUENZA LIKE ILLNESS 3 0.0000
890 PROCEDURAL PAIN 1 0.0000
891 ARTHROPATHY 2 0.0000
892 FEELING COLD 1 0.0000
893 INFLUENZA 4 0.0000
894 BLISTER 2 0.0000
895 RED BLOOD CELL COUNT DECREASED 1 0.0000
896 HYPERSOMNIA 1 0.0000
897 HERPES ZOSTER 2 0.0000
898 DECREASED APPETITE 8 0.0000
899 ABDOMINAL PAIN 8 0.0000
900 VOMITING 16 0.0000
901 PSYCHOTIC DISORDER 1 0.0000
902 MATERNAL EXPOSURE DURING PREGNANCY 3 0.0000
903 APHASIA 1 0.0000
904 ILL-DEFINED DISORDER 2 0.0000
905 EPILEPSY 1 0.0000
906 ALANINE AMINOTRANSFERASE INCREASED 2 0.0000
907 ADVERSE EVENT 3 0.0000
908 WEIGHT DECREASED 9 0.0000
909 EXPOSURE DURING PREGNANCY 2 0.0000
910 CONSTIPATION 7 0.0000
911 PYREXIA 11 0.0000
912 NEUROPATHY PERIPHERAL 3 0.0000
913 MOVEMENT DISORDER 1 0.0000
914 HYPERHIDROSIS 4 0.0000
915 NIGHT SWEATS 1 0.0000
916 LACTIC ACIDOSIS 1 0.0000
917 AMNESIA 2 0.0000
918 PSORIASIS 4 0.0000
919 SKIN DISORDER 1 0.0000
920 ANGER 1 0.0000
921 DIARRHOEA 19 0.0000
922 HEART RATE DECREASED 1 0.0000
923 LYMPHADENOPATHY 1 0.0000
924 SYSTEMIC LUPUS ERYTHEMATOSUS 1 0.0000
925 PRODUCT ADHESION ISSUE 1 0.0000
926 CEREBRAL HAEMORRHAGE 1 0.0000
927 CRYING 1 0.0000
928 C-REACTIVE PROTEIN INCREASED 1 0.0000
929 HYPERGLYCAEMIA 1 0.0000
930 PANIC ATTACK 1 0.0000
931 RESTLESSNESS 1 0.0000
932 AGITATION 2 0.0000
933 EYE SWELLING 1 0.0000
934 HOT FLUSH 2 0.0000
935 INTESTINAL OBSTRUCTION 1 0.0000
936 MUSCULAR WEAKNESS 3 0.0000
937 GENERAL PHYSICAL HEALTH DETERIORATION 3 0.0000
938 ABNORMAL BEHAVIOUR 1 0.0000
939 DISORIENTATION 1 0.0000
940 HYPOTENSION 5 0.0000
941 NEUTROPHIL COUNT DECREASED 1 0.0000
942 OSTEOPOROSIS 1 0.0000
943 RECTAL HAEMORRHAGE 1 0.0000
944 LIVER DISORDER 1 0.0000
945 THERAPEUTIC PRODUCT EFFECT DECREASED 1 0.0000
946 SUICIDAL IDEATION 2 0.0000
947 SKIN DISCOLOURATION 1 0.0000
948 COGNITIVE DISORDER 1 0.0000
949 ARRHYTHMIA 1 0.0000
950 OCULAR HYPERAEMIA 1 0.0000
951 PULMONARY EMBOLISM 2 0.0000
952 COMA 1 0.0000
953 RENAL CANCER 1 0.0000
954 RASH ERYTHEMATOUS 1 0.0000
955 HYPOGLYCAEMIA 1 0.0000
956 ALOPECIA 4 0.0000
957 HYPOAESTHESIA 3 0.0000
958 HOSPITALISATION 3 0.0000
959 MUSCULOSKELETAL PAIN 1 0.0000
960 PANCREATITIS 1 0.0000
961 DRUG INTERACTION 3 0.0000
962 DISTURBANCE IN ATTENTION 1 0.0000
963 TREATMENT NONCOMPLIANCE 1 0.0000
964 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 1 0.0000
965 HAEMATOCHEZIA 1 0.0000
966 CEREBROVASCULAR ACCIDENT 3 0.0000
967 FLATULENCE 1 0.0000
968 RHEUMATOID ARTHRITIS 2 0.0000
969 LETHARGY 1 0.0000
970 IRRITABILITY 1 0.0000
971 EMOTIONAL DISTRESS 2 0.0000
972 PLEURAL EFFUSION 1 0.0000
973 INTENTIONAL OVERDOSE 1 0.0000
974 DEATH 13 0.0000
975 HEPATIC ENZYME INCREASED 1 0.0000
976 DYSGEUSIA 1 0.0000
977 INJECTION SITE HAEMORRHAGE 1 0.0000
978 CARDIAC FAILURE 1 0.0000
979 PROSTATE CANCER 1 0.0000
980 CARDIAC ARREST 1 0.0000
981 TREATMENT FAILURE 1 0.0000
982 GASTROINTESTINAL HAEMORRHAGE 1 0.0000
983 MYOCARDIAL INFARCTION 2 0.0000
984 PRODUCT STORAGE ERROR 1 0.0000
985 MUSCULOSKELETAL STIFFNESS 1 0.0000
986 ADVERSE DRUG REACTION 1 0.0000
987 DRUG INTOLERANCE 1 0.0000
988 HAEMOGLOBIN DECREASED 1 0.0000
989 HAEMORRHAGE 1 0.0000